July 01, 2025 By Joan Tupponce With the popularity of weight loss and obesity medications soaring, its important to know all the ins and outs of glucagon-like peptide-1 (GLP-1) receptor agonists
Glucagon-like peptide-1 (GLP-1) receptor agonists are medications approved by the FDA for managing type 2 diabetes and, in some formulations, for chronic weight management
If needed, consider a gentle stool softener
Whether youre focused on weight loss, appetite control, or blood sugar management, your pharmacist can help clarify if your prescribed dose fits your needs
[9] STEP-1 : In patients with obesity without diabetes, semaglutide resulted in ~15% mean weight loss over 68 weeks
your provider will follow the appropriate clinical protocols to start you at the lowest dose and move up as needed